230 related articles for article (PubMed ID: 8503864)
1. Structural requirements for the interaction between tissue factor and factor VII: characterization of chymotrypsin-derived tissue factor polypeptides.
O'Brien DP; Anderson JS; Martin DM; Byfield PG; Tuddenham EG
Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):7-12. PubMed ID: 8503864
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
[TBL] [Abstract][Full Text] [Related]
3. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.
Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L
Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820
[TBL] [Abstract][Full Text] [Related]
4. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.
Toso R; Pinotti M; High KA; Pollak ES; Bernardi F
Biochem J; 2002 Apr; 363(Pt 2):411-6. PubMed ID: 11931672
[TBL] [Abstract][Full Text] [Related]
5. Factor VII mutant V154G models a zymogen-like form of factor VIIa.
Toso R; Bernardi F; Tidd T; Pinotti M; Camire RM; Marchetti G; High KA; Pollak ES
Biochem J; 2003 Feb; 369(Pt 3):563-71. PubMed ID: 12358603
[TBL] [Abstract][Full Text] [Related]
6. Predicted solution structure of zymogen human coagulation FVII.
Perera L; Darden TA; Pedersen LG
J Comput Chem; 2002 Jan; 23(1):35-47. PubMed ID: 11913388
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the N-terminal EGF-like domain from human factor VII.
Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T
Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor pathway.
McVey JH
Baillieres Clin Haematol; 1994 Sep; 7(3):469-84. PubMed ID: 7841596
[TBL] [Abstract][Full Text] [Related]
9. The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex.
Ndonwi M; Broze G; Bajaj SP
J Thromb Haemost; 2005 Jan; 3(1):112-8. PubMed ID: 15634274
[TBL] [Abstract][Full Text] [Related]
10. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X.
Doñate F; Kelly CR; Ruf W; Edgington TS
Biochemistry; 2000 Sep; 39(37):11467-76. PubMed ID: 10985793
[TBL] [Abstract][Full Text] [Related]
11. Synthetic peptide analogs of tissue factor and factor VII which inhibit factor Xa formation by the tissue factor/factor VIIa complex.
Rønning HF; Risøen UC; Orning L; Sletten K; Sakariassen KS
Thromb Res; 1996 Oct; 84(2):73-81. PubMed ID: 8897697
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male.
O'Brien DP; Gale KM; Anderson JS; McVey JH; Miller GJ; Meade TW; Tuddenham EG
Blood; 1991 Jul; 78(1):132-40. PubMed ID: 2070047
[TBL] [Abstract][Full Text] [Related]
13. Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304-->Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor.
Matsushita T; Kojima T; Emi N; Takahashi I; Saito H
J Biol Chem; 1994 Mar; 269(10):7355-63. PubMed ID: 8125953
[TBL] [Abstract][Full Text] [Related]
14. Structural modulation of factor VIIa by full-length tissue factor (TF
Prasad R; Sen P
J Biomol Struct Dyn; 2018 Feb; 36(3):621-633. PubMed ID: 28150568
[TBL] [Abstract][Full Text] [Related]
15. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.
Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP
Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166
[TBL] [Abstract][Full Text] [Related]
16. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.
Wildgoose P; Foster D; Schiødt J; Wiberg FC; Birktoft JJ; Petersen LC
Biochemistry; 1993 Jan; 32(1):114-9. PubMed ID: 8418832
[TBL] [Abstract][Full Text] [Related]
17. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
18. Molecular interaction between factor VII and tissue factor.
Higashi S; Iwanaga S
Int J Hematol; 1998 Apr; 67(3):229-41. PubMed ID: 9650444
[TBL] [Abstract][Full Text] [Related]
19. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
Jin J; Perera L; Stafford D; Pedersen L
J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
[TBL] [Abstract][Full Text] [Related]
20. The factor VII zymogen structure reveals reregistration of beta strands during activation.
Eigenbrot C; Kirchhofer D; Dennis MS; Santell L; Lazarus RA; Stamos J; Ultsch MH
Structure; 2001 Jul; 9(7):627-36. PubMed ID: 11470437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
